Correlation Between Daiichi Sankyo and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Daiichi Sankyo and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Daiichi Sankyo and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Daiichi Sankyo and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Daiichi Sankyo and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Daiichi Sankyo with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Daiichi Sankyo and Takeda Pharmaceutical.
Diversification Opportunities for Daiichi Sankyo and Takeda Pharmaceutical
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Daiichi and Takeda is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Daiichi Sankyo and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Daiichi Sankyo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Daiichi Sankyo are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Daiichi Sankyo i.e., Daiichi Sankyo and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between Daiichi Sankyo and Takeda Pharmaceutical
Assuming the 90 days horizon Daiichi Sankyo is expected to generate 2.11 times more return on investment than Takeda Pharmaceutical. However, Daiichi Sankyo is 2.11 times more volatile than Takeda Pharmaceutical Co. It trades about 0.08 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about -0.07 per unit of risk. If you would invest 3,050 in Daiichi Sankyo on September 1, 2024 and sell it today you would earn a total of 224.00 from holding Daiichi Sankyo or generate 7.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Daiichi Sankyo vs. Takeda Pharmaceutical Co
Performance |
| Timeline |
| Daiichi Sankyo |
| Takeda Pharmaceutical |
Daiichi Sankyo and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Daiichi Sankyo and Takeda Pharmaceutical
The main advantage of trading using opposite Daiichi Sankyo and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Daiichi Sankyo position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.| Daiichi Sankyo vs. Astellas Pharma | Daiichi Sankyo vs. Bristol Myers Squibb | Daiichi Sankyo vs. Bayer AG | Daiichi Sankyo vs. AstraZeneca PLC |
| Takeda Pharmaceutical vs. Astellas Pharma | Takeda Pharmaceutical vs. Daiichi Sankyo | Takeda Pharmaceutical vs. Chugai Pharmaceutical Co | Takeda Pharmaceutical vs. Bayer AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |